Dr. Daniel N. Efiom-Ekaha

As a physician scientist in the hematological malignancies and stem cell transplantation division with Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins, my focus is on the various aspects of cellular therapy in the treatment of hematological malignancies. My primary research focus is to develop strategies to prevent relapse of hematological malignancies following allogeneic stem cell transplantation. Additionally, I serve as the director of the adult CAR T program for hematological malignancies as we grow our CAR T program to help patients with advanced hematological malignancies. My academic interest in this space lies in studying the aspects of toxicity of CAR T cell therapy with an aim to improve long term outcomes in these patients. Among hematological malignancies, myeloproliferative disorders are my area of interest and I work to study newer drugs in early phase of development and also its treatment using allogeneic stem cell transplantation. Patient appointments: 410-955-8893. Dr. Jain is rated as a Distinguished provider by MediFind in the treatment of Splenomegaly. Her top areas of expertise are Myelofibrosis, Myeloproliferative Neoplasms (MPN), Splenomegaly, Bone Marrow Transplant, and Splenectomy.

Meide Lu is a Hematologist Oncology specialist and a Hematologist in West Reading, Pennsylvania. Dr. Lu is rated as a Distinguished provider by MediFind in the treatment of Splenomegaly. His top areas of expertise are Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and ALK-Positive Non-Small Cell Lung Cancer.

Vinni Juneja is a Hematologist Oncology specialist and a Hematologist in Silver Spring, Maryland. Dr. Juneja is rated as a Distinguished provider by MediFind in the treatment of Splenomegaly. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Thrombocytopenia, and Paget Disease of the Breast. Dr. Juneja is currently accepting new patients.